1.
LC-MS/MS determination of itraconazole liposome in plasma and tissue of mice
伊曲康唑脂质体在大鼠体内药动学研究
2.
Tissue Distribution of Itraconazole Liposomes in Mice
伊曲康唑脂质体在小鼠体内的组织分布
3.
Study on the Preparation and Transdermal Penetration of Itraconazole Ethosome Gel
伊曲康唑醇质体的制备及体外经皮渗透研究
4.
Preparation and Quality Evaluation of Itraconazole Self-emulsifying Solution
伊曲康唑自乳化液的制备及质量评价
5.
Study on Relative bioavailalility and bilequiralence of Itraconazsle Dispersible Tablets
伊曲康唑分散片人体生物等效性研究
6.
Pharmacokinetics and Bioequivalence of Itraconazole Capsules in Healthy Volunteers after High Fat Diet
伊曲康唑胶囊在健康人高脂饮食后的药动学及生物等效性
7.
Activities of Terbinafine in Combination with Itraconazole and Fluconazole Against Isolates of Candida albicans In Vitro
特比萘芬与伊曲康唑和氟康唑体外联合抗白念珠菌的实验分析
8.
Prescription craft and quality control standard of itraconzole tablets
伊曲康唑片处方工艺及质量检测标准的研究
9.
Life quality of onychomycosis patients and the effects of oral itraconazole intermittent pulse therapy
甲真菌病患者生活质量及口服伊曲康唑间歇冲击疗法对其的影响
10.
Clinical Efficacy of Fluconazole and Itraconazole Treating Sporotrichosis and Antifungal Susceptibility Testing in Vitro
氟康唑、伊曲康唑治疗孢子丝菌病的临床疗效及体外抗真菌药敏试验研究
11.
Morphological changes of dermatophytes treated by itraconazole
伊曲康唑对皮肤癣菌形态学影响研究
12.
Adverse drug reactions induced by itraconazole:literature review of 38 cases
伊曲康唑致不良反应38例文献分析
13.
Observing the Curative Effect of Itraconazole in Treatment on Sporotrichosis
伊曲康唑治疗孢子丝菌病的疗效观察
14.
Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;
伊立替康脂质体的制备及体内外行为研究
15.
Research on the resistance mechanism of Aspergillus fumigatus to itraconazole
烟曲霉对伊曲康唑耐药机制的研究现况
16.
Evaluating the efficacy of the treatments for beaded vaginitis between oral itraconazole and fluconazole
口服伊曲康唑与氟康唑治疗念珠性阴道炎疗效比较
17.
Content Determination of Itraconazole and Its Metabolit Hydroxy-itraconazole in Rabbit Plasma by HPLC-Fluorometric Methods
HPLC-荧光法测定兔血浆中伊曲康唑及其代谢产物羟基伊曲康唑的浓度
18.
CONCLUSION: These two kinds of itraconazole capsules are bioequivalent.
结论2种伊曲康唑胶囊具有生物等效性。